Of particular interest, the significantly lowered PRS for intelligence in our cohort could imply that even with symptomatic treatment leading to seizure freedom, or with disease-modifying treatment increasing SCN1A expression, the full phenotype of Dravet syndrome may not be entirely reversible. Here, SCN1A is linked to Dravet syndrome.